JP2010539893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010539893A5 JP2010539893A5 JP2010525273A JP2010525273A JP2010539893A5 JP 2010539893 A5 JP2010539893 A5 JP 2010539893A5 JP 2010525273 A JP2010525273 A JP 2010525273A JP 2010525273 A JP2010525273 A JP 2010525273A JP 2010539893 A5 JP2010539893 A5 JP 2010539893A5
- Authority
- JP
- Japan
- Prior art keywords
- stretch
- nucleic acid
- acid according
- nucleotides
- box
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07018750 | 2007-09-24 | ||
| EP07018750.5 | 2007-09-24 | ||
| PCT/EP2008/008097 WO2009040113A2 (en) | 2007-09-24 | 2008-09-24 | C5a BINDING NUCLEIC ACIDS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010539893A JP2010539893A (ja) | 2010-12-24 |
| JP2010539893A5 true JP2010539893A5 (enExample) | 2011-11-04 |
| JP5798320B2 JP5798320B2 (ja) | 2015-10-21 |
Family
ID=40174751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525273A Expired - Fee Related JP5798320B2 (ja) | 2007-09-24 | 2008-09-24 | Ｃ５ａに結合する核酸 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8507456B2 (enExample) |
| EP (2) | EP2562256A3 (enExample) |
| JP (1) | JP5798320B2 (enExample) |
| KR (1) | KR20100072185A (enExample) |
| CN (1) | CN101809154A (enExample) |
| AU (1) | AU2008303775A1 (enExample) |
| BR (1) | BRPI0817260A2 (enExample) |
| CA (1) | CA2700441A1 (enExample) |
| MX (1) | MX2010003109A (enExample) |
| RU (1) | RU2010116245A (enExample) |
| WO (1) | WO2009040113A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
| WO2010108657A2 (en) * | 2009-03-23 | 2010-09-30 | Noxxon Pharma Ag | C5a binding nucleic acids and the use thereof |
| WO2011038301A2 (en) * | 2009-09-25 | 2011-03-31 | Xoma Technology Ltd. | Screening methods |
| WO2012149198A2 (en) * | 2011-04-26 | 2012-11-01 | Regado Biosciences, Inc. | A method for manufacturing pegylated oligonucleotides |
| EP2718866B1 (en) * | 2011-06-07 | 2020-09-09 | Koninklijke Philips N.V. | Providing nucleotide sequence data |
| WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| US9518265B2 (en) | 2012-01-10 | 2016-12-13 | Noxxon Pharma Ag | C5a binding nucleic acids |
| CN111443069A (zh) | 2013-10-28 | 2020-07-24 | 多茨技术公司 | 过敏原检测 |
| WO2015103438A2 (en) | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| CN106860867A (zh) * | 2017-02-23 | 2017-06-20 | 中山大学 | 己糖激酶2特异性抑制剂在急性中枢神经系统损伤疾病中的应用 |
| EP3553521A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Gingivitis diagnostic methods, uses and kits |
| EP4620474A1 (en) | 2024-03-20 | 2025-09-24 | APTARION biotech AG | Method of treating a disorder with a c5a inhibitor |
| TW202602466A (zh) | 2024-03-20 | 2026-01-16 | 德商艾普塔里昂生技公司 | 以Ｃ５ａ抑制劑治療疾病之方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| US6395888B1 (en) * | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
| US6395029B1 (en) | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| EP1306382A1 (de) | 2001-10-26 | 2003-05-02 | Noxxon Pharma AG | Modifizierte L-Nukleinsäure |
| ATE441706T1 (de) | 2002-02-20 | 2009-09-15 | Gen Hospital Corp | Konjugate mit biologisch abbaubarem polymer und verwendung dafür |
| MXPA05011022A (es) | 2003-04-13 | 2006-04-27 | Enzon Pharmaceuticals Inc | Profarmacos oligonucleotidos polimericos. |
| GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| US20070116710A1 (en) * | 2004-02-03 | 2007-05-24 | Leonard Bell | Methods of treating hemolytic anemia |
| US20090281296A1 (en) | 2004-02-09 | 2009-11-12 | Supramol Parenteral Colloid Gmbh | Process for the production of conjugates from polysaccharides and polynucelotides |
| US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
| DK1727567T3 (da) * | 2004-02-12 | 2013-10-14 | Archemix Llc | Aptamer-terapeutiske midler nyttige i behandling af komplementrelaterede forstyrrelser |
| WO2005099768A2 (en) | 2004-03-23 | 2005-10-27 | Complex Biosystems Gmbh | Polymeric prodrug with a self-immolative linker |
| CA2585664C (en) | 2004-11-05 | 2014-05-20 | The Children's Hospital Of Philadelphia | Biodegradable linkers for molecular therapies |
| EP2596807B1 (en) * | 2006-03-08 | 2015-12-16 | Archemix LLC | Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders |
| MX2009002859A (es) | 2006-09-15 | 2009-03-30 | Enzon Pharmaceuticals Inc | Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos. |
| EP2061901A2 (en) | 2006-10-31 | 2009-05-27 | Noxxon Pharma AG | Methods for detection of a single- or double-stranded nucleic acid molecule |
| WO2010108657A2 (en) * | 2009-03-23 | 2010-09-30 | Noxxon Pharma Ag | C5a binding nucleic acids and the use thereof |
-
2008
- 2008-09-24 CA CA2700441A patent/CA2700441A1/en not_active Abandoned
- 2008-09-24 CN CN200880108439A patent/CN101809154A/zh active Pending
- 2008-09-24 KR KR1020107005454A patent/KR20100072185A/ko not_active Withdrawn
- 2008-09-24 RU RU2010116245/10A patent/RU2010116245A/ru not_active Application Discontinuation
- 2008-09-24 AU AU2008303775A patent/AU2008303775A1/en not_active Abandoned
- 2008-09-24 MX MX2010003109A patent/MX2010003109A/es not_active Application Discontinuation
- 2008-09-24 BR BRPI0817260-9A2A patent/BRPI0817260A2/pt not_active IP Right Cessation
- 2008-09-24 WO PCT/EP2008/008097 patent/WO2009040113A2/en not_active Ceased
- 2008-09-24 JP JP2010525273A patent/JP5798320B2/ja not_active Expired - Fee Related
- 2008-09-24 US US12/679,307 patent/US8507456B2/en not_active Expired - Fee Related
- 2008-09-24 EP EP12006735.0A patent/EP2562256A3/en not_active Withdrawn
- 2008-09-24 EP EP08834443A patent/EP2205734A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010116245A (ru) | НУКЛЕИНОВЫЕ КИСЛОТЫ, СВЯЗЫВАЮЩИЕ C5a | |
| US12070458B2 (en) | Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders | |
| Gombert et al. | Outcome of elective and emergency open thoraco-abdominal aortic aneurysm repair in 255 cases: a retrospective single centre study | |
| EA022429B1 (ru) | АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ β-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ | |
| Scott et al. | Hemodynamic, hormonal, and renal actions of phosphodiesterase-9 inhibition in experimental heart failure | |
| CN101553565A (zh) | 从血液特别是外周血扩增成体干细胞的方法及在医药领域的相关应用 | |
| US11565002B2 (en) | Thrombus imaging aptamers and methods of using same | |
| US9603831B2 (en) | Artemisinin and its derivatives for use in the treatment of kidney disease | |
| Muchtar et al. | Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines | |
| WO2019006692A1 (zh) | 用于治疗、改善或预防神经系统相关病症的化合物及其用途 | |
| Takeuchi | Left atrial diverticula supplied by the anomalistic branch of the right coronary artery | |
| CN112121042A (zh) | Pso用于制备抗败血症及其诱发的心肌损伤药物的应用 | |
| CN118772296B (zh) | 一种多肽药物及其在预防或治疗腹主动脉瘤中的应用 | |
| CN106562944A (zh) | Fty720在制备预防或治疗缺血性脑卒中的药物中的应用 | |
| WO2017147044A1 (en) | Peptides and methods for treatment of neurodegenerative diseases | |
| WO2023217249A1 (zh) | HTR2b激活剂在改善脑缺血再灌注损伤中的应用 | |
| JPWO2005072773A1 (ja) | 赤血球機能修飾物質 | |
| JP2024069733A (ja) | 心不全およびその併発疾患の治療法、治療剤および診断法。 | |
| RU2644280C1 (ru) | Способ получения противоопухолевого коньюгата на основе человеческого сывороточного альбумина, содержащего терапевтические и контрастирующий агенты | |
| US20250177479A1 (en) | Depsipeptide-based amphiphilic buliding block to inhibit protein-protein interactions, nanostructure comprised thereof and uses thereof | |
| EP4522191A1 (en) | Agents inducing vascularisation | |
| JP4582561B2 (ja) | 移植による血管病変の発生抑制剤 | |
| Shi et al. | Development of Oxytocin-and Vasopressin-Network in the Supraoptic and Paraventricular Nuclei of Fetal Sheep | |
| CN121868277A (zh) | Slco5a1在制备用于治疗和/或预防心力衰竭药物中的应用 | |
| OTHMAN | A NOVEL METHOD FOR DIALYSIS, DERMODIALYSIS OR DERMO-HEMODIALYSIS, CAN ALSO BE USED AS THE TREATMENT OF COVID 19 AND OTHER INFECTIONS BY RAPIDLY BOOSTING THE IMMUNE SYSTEM |